Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
Adapting to modern threats, Europe's security future hinges on strategic foresight, unity and the inclusivity of NATO members ...
In September 2024, the European Commission (EC) granted marketing authorization for an updated formulation of Moderna's COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.
As the first quarter of the 21st century ends with artificial intelligence (AI) taking center stage, the European Union (EU) is in the spotlight for going against the tide and setting rules for the AI ...
As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.
To effectively counter modern security challenges, Europe must strengthen its own defense industry. One of the key elements ...
Moderna, Inc. (NASDAQ:MRNA) today announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway and North Macedonia. Under the ...
Moderna, Inc. (NASDAQ:MRNA) today announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway and North Macedonia. Under the resulting ...